The "Drugs of Abuse Testing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The current report offers a detailed picture of the drug abuse testing market. The market was valued at $5.2 Billion in 2021 and is expected to Reach $8.1 Billion by 2027 at a CAGR of 9.3%.

This report highlights the current and future market potential for drug abuse testing and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2027 and key market players.

This report discusses drug abuse testing and its various resources. It covers the overall drug abuse testing market, including drug testing products. The report further analyzes the market based on products, covering analyzers, consumables, laboratory services, and point-of-care devices. In addition, the report also analyzes various sample types in drug abuse testing that include blood, hair, sweat, oral, urine, and others. Furthermore, a complete regional analysis of the market is also presented in the report.

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (which includes Latin America, the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China, and India) are covered in regional segments.

For market estimates, data has been provided for 2021 as the base year, with forecasts for 2022 through 2027. Estimated values are based on revenue generated by drug abuse testing companies as total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Companies Mentioned

• Abbott Diagnostics
• Acon Laboratories Inc.
• Agilent Technologies, Inc.
• Alfa Scientific Designs, Inc.
• American Bio Medica
• Bio-Rad Laboratories, Inc.
• Confirm Biosciences
• Danaher Corp.
• F. Hoffmann-La Roche Ltd.
• Identa Corp.
• Lifesign LLC
• Mavand Solutions
• Medtox Diagnostics
• Mossman Associates
• Mp Biomedicals
• Nano-Ditech Corp.
• One Step Detect Associates
• Orasure
• Ortho-Clinical Diagnostics
• Prechek Bio
• Princeton Biomeditech
• Psychemedics
• Quest Diagnostics Inc.
• Randox Laboratories Ltd.
• Redwood Toxicology Laboratory, Inc.
• Shimadzu Corp.
• Siemens Healthineers
• Thermo Fisher Scientific, Inc.
• Ucp Biosciences

Report Includes

• 23 data tables and 42 additional tables
• A comprehensive overview and an up-to-date analysis of the global markets for drugs of abuse (DOA) testing
• Analyses of the global market trends, with historic market revenue (sales figures) for 2021, estimates for 2022, forecasts for 2023, and projections of compound annual growth rates (CAGRs) through 2027
• Highlights of the upcoming market potential for DOA testing industry along with a detailed analysis of the competitive environment, industry trends, opportunities and penetration of emerging technologies within the marketplace
• Estimation of the actual market size and revenue forecast for the global drug abuse testing market in USD million values, and its corresponding market share analysis based on the product, sample type, drug type, testing type, end user, and region
• Technology assessment of the current and possible future legislation affecting the market in the U.S. and other emerging economies, and their influence in the market developments
• Statistical information covering drug abuse along with its trends as well as drug classes across the key geographic regions
• A comparative study and Porter's Five Forces analysis considering both the micro and macro environmental factors prevailing in the market for drugs of abuse testing
• Review of the key patent grants and patent applications on drug abuse testing technologies
• Identification of the major stakeholders and analysis of the company competitive landscape based on their recent market developments, financial performance, and segmental revenues

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

3.1 Overview

3.2 Testing Technologies

3.2.1 Urine Testing

3.2.2 Other Testing

3.3 Single Tests Vs. Multiparameter Tests

3.4 Doa Screening

3.5 Porter's Five Forces Analysis

3.6 Future Outlook

3.7 Assessment of Covid-19's Impact on the Market

Chapter 4 Market Dynamics

4.1 Market Drivers

4.1.1 Government Initiatives for Drug Abuse Testing

4.1.2 Increased Drug Trafficking

4.2 Market Restraints

4.2.1 Drug Testing at the Workplace Considered a Violation of Privacy Rights

4.3 Market Opportunities

4.3.1 Increasing Concern for Drink-Driving

Chapter 5 Regulatory Scenario

Chapter 6 Global Drugs of Abuse Testing Market by Drug Type

Chapter 7 Global Drugs of Abuse Testing Market by End-user

Chapter 8 Global Drugs of Abuse Testing Market by Sample Type

Chapter 9 Global Drugs of Abuse Testing Market by Product

Chapter 10 Global Drugs of Abuse Testing Market by Testing Type

Chapter 11 Market Breakdown by Region

Chapter 12 Patent Analysis

Chapter 13 Competitive Landscape Analysis

Chapter 14 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/ash9xf-of-abuse?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230227005405/en/

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.